| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.07 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |